journal article

PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies

Authors
Publication date
1 November 2011
Publisher
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/j.jval.2011.08.135...
      Last time updated on 05/06/2019

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fj.jval.2011...
      Last time updated on 23/03/2019

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/j.jval.2011.08.135...
      Last time updated on 06/05/2017